4.5 Article

Synthesis and characterization of novel oxazines and demonstration that they specifically target cyclooxygenase 2

Journal

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 25, Issue 15, Pages 2931-2936

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2015.05.047

Keywords

COX2; Oxazines; SCS-Bi2O3; Proinflammatory disease

Funding

  1. University Grants Commission [41-257-2012-SR]
  2. Vision Group Science and Technology, Department of Science and Technology [SR/FT/LS-142/2012]
  3. DST-JSPS [DST/INT/JAP/P-79/09]
  4. DST Indo-Korea [INT/indo-korea/122/2011-12]
  5. DST-PURSE
  6. Russian President's Council

Ask authors/readers for more resources

In the present study, we used solution combustion synthesis-bismuth oxide (Bi2O3) as catalyst for the simple and efficient synthesis of 1,2-oxazine based derivatives of 6-fluoro-3-(piperidin-4yl) benzo[d] isoxazoles, 1-arylpiperazine and carbazoles. (4aR,8aR)-4-(4-Methoxyphenyl)-3-((4-(4-methoxyphenyl) piperazin-1-yl) methyl)-4a, 5,6,7,8,8a-hexahydro-4H-benzo[e][1,2] oxazine was found to be the most potent compound with a high degree of selectivity in inhibition towards COX2 (1.7 mu M) over COX1 (40.4 mu M) demonstrating the significance of 1,2-oxazine derivatives in developing COX2 specific inhibitors. Molecular docking analyses demonstrated that an isoleucine residue in the active site of COX1 is responsible for lower affinity to COX1 and increased potency towards COX2. Overall, our study reveals that the new 1,2-oxazine-based small molecules qualify as lead structures in developing COX2-specific inhibitors for anti-inflammatory therapy. (C) 2015 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available